Ontex Group (ONTEX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 delivered 4% volume growth, with double-digit increases in adult care and North America baby care, supported by innovation and new contracts.
Achieved key transformation milestones, including successful social negotiations in Belgium and agreement to sell Brazilian business.
Adjusted EBITDA margin rose to 12%, up 2.4 percentage points year-over-year, with adjusted EBITDA up 29%.
Leverage reduced to 2.4x, with net debt at €579 million, reflecting strong EBITDA and asset disposals.
2024 outlook confirmed for margin, free cash flow, and leverage, with revenue growth guidance updated.
Financial highlights
Q3 revenue from continuing operations was €468 million, up 1.7% like-for-like and 2.4% year-over-year, driven by 4.4% volume/mix improvement.
Adjusted EBITDA reached €56 million in Q3, up 29% year-over-year, with margin at 12%.
Cost transformation program delivered €40 million in savings, reducing operating costs by 4%.
Sales prices declined 2.6% year-over-year due to lower raw material costs, but stabilized sequentially.
Net financial debt reduced by €9 million in the quarter to €579 million; leverage ratio improved to 2.4x.
Outlook and guidance
2024 outlook confirmed: adjusted EBITDA margin at 12%, free cash flow above €20 million, leverage below 2.5x.
Revenue growth guidance revised to 2%-3% due to phased onboarding of new North America customers.
Strong double-digit growth in North America baby care expected to continue into 2025 and 2026.
Latest events from Ontex Group
- Revenue and EBITDA fell in 2025, but debt reduction and 2026 recovery targets are in place.ONTEX
Q4 202512 Feb 2026 - Strong H1 2024 results and raised outlook as volume growth and cost savings boost profitability.ONTEX
Q2 20242 Feb 2026 - Strong volume-driven growth, margin expansion, and lower leverage set the stage for 2025.ONTEX
Q4 202414 Dec 2025 - Q1 2025 margin resilience and strategic actions support a positive 2025 growth outlook.ONTEX
Q1 202528 Nov 2025 - H1 2025 saw revenue and margin declines, but divestments reduced net debt and H2 recovery is expected.ONTEX
Q2 202516 Nov 2025 - H1 2025 saw a 4% revenue and 22% EBITDA drop, but H2 recovery is expected.ONTEX
Q2 2025 TU16 Nov 2025 - Q3 revenue and margin improved sequentially, with guidance and leverage targets reaffirmed.ONTEX
Q3 20254 Nov 2025